Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECARDIA: Perindopril in Preclinical Dilated Cardiomyopathy
NCT01583114Phase 3Terminated
- Sponsor
- Inserm
- Start
- Dec 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial in dilated cardiomyopathy (DCM) comparing Perindopril Arm with Placebo Arm (2 arms). Primary endpoint: Change in left ventricle diameter / volume / ejection fraction at 36 months. Started Dec 2011; status: terminated.
02
Drugs
perindopril
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01583114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01583114.